TORRENT PHARMACEUTICALS
|
The Current P/S Ratio of TORRENT PHARMACEUTICALS is 9.52.
Share Price | ₹3,159.4 | Nov 07,2024 |
Market Cap | ₹106,914.1 Cr | |
Sales-TTM | ₹11,225.0 Cr | TTM-Consolidated Results |
Price/Sales | 9.52x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of TORRENT PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹106,914.1 Cr] as on Nov 07,2024
(/) Sales [ ₹11,225.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 9.52x ]
Thus, for TORRENT PHARMACEUTICALS , the investors are currently willing to pay '9.52 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of TORRENT PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of TORRENT PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of TORRENT PHARMACEUTICALS
PS Ratio Performance Analysis for TORRENT PHARMACEUTICALS
- TORRENT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 5.75x.
- TORRENT PHARMACEUTICALS 's operated at median p/e ratio of 5.41x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, TORRENT PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 8.21x.
- TORRENT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 4.2x.
How does TORRENT PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
TORRENT PHARMACEUTICALS | 11,225.0 | 9.52 | 106,914.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.54 | 429,841.0 |
CIPLA LTD | 26,512.0 | 4.79 | 127,063.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.57 | 107,398.0 |
ZYDUS LIFESCIENCES LTD | 20,615.3 | 4.75 | 97,866.3 |
DIVIS LABORATORIES LTD | 8,185.0 | 19.33 | 158,179.0 |
MANKIND PHARMA LTD | 11,018.0 | 9.91 | 109,234.0 |
LUPIN LTD | 20,797.1 | 4.63 | 96,282.2 |
AUROBINDO PHARMA LTD | 29,718.4 | 2.64 | 78,437.3 |
ABBOTT INDIA LTD | 6,066.1 | 9.91 | 60,116.9 |
ALKEM LABORATORIES LTD | 12,731.7 | 5.37 | 68,407.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs TORRENT PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.64x |
Max industry PS | 19.33x |
Median industry PS | 5.37x |
Average industry PS | 7.54x |
You may also like the below Video Courses